SPDR S&P Pharmaceuticals ETF
XPH
XPH
74 hedge funds and large institutions have $141M invested in SPDR S&P Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 26 closing their positions.
Holders
74
Holders Change
-11
Holders Change %
-12.94%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
19
Reduced
21
Closed
26
Calls
$883K
Puts
$297K
Net Calls
+$586K
Net Calls Change
-$239K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$28.3M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$8.72M |
| 3 |
3
Barclays
London,
United Kingdom
|
$1.74M |
| 4 |
4
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$2.11M |
| 5 |
5
LPL Financial
San Diego,
California
|
$1.96M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
102
Jane Street
New York
| – | – | – | – |
|